IGI Logo

NFOs open 16th January 2024 and close on 30th January 2024

WhiteOak Capital Mutual Fund today announced the launch of two new thematic fund offers - the ‘WhiteOak Capital Banking & Financial Services Fund’ and ‘WhiteOak Capital Pharma and Healthcare Fund’. Both the NFOs open today 16th January, 2024 and will close on 30th January, 2024.  The two funds by WhiteOak Capital Mutual Fund are open-ended equity schemes. WhiteOak Capital Banking & Financial Services Fund seeks to invest predominantly in Banks, NBFCs and companies engaged in the broader financial services sector including but not limited to insurance companies, asset management companies, capital market intermediaries, market infrastructure, fintechs etc., while the WhiteOak Capital Pharma and Healthcare Fund intends to invest primarily in Pharma and Healthcare companies.

Aashish P Somaiyaa, CEO, WhiteOak Capital Asset Management said, “WhiteOak Capital is uniquely positioned to offer thematic funds because of its large research team comprising a deep bench of seasoned professionals providing width as well as depth of coverage. We have launched these two thematic schemes to provide investors with an opportunity to invest in key growth themes in the Indian equity market in years to come. BFSI remains under-penetrated but the JAM Trinity - Jan Dhan, Aadhaar, and Mobile - has been a key enabler in transforming the digital landscape in India as applied to banking and financial services. We are witnessing demographics being actualized as seen in a wide and increasing base of new customers and investors. Reforms over the years have resulted in the Indian banking sector’s profitability and balance sheet being at its healthiest in a decade. On the other hand, Healthcare has emerged as one of the prominent themes in India with S&P BSE Healthcare Index market cap being at 19.7 Tn as of Dec’23. We believe that the Healthcare theme with multiple sub-sectors has the highest alpha potential due to wide heterogeneity of businesses within and the WhiteOak team is uniquely positioned to exploit the same and deliver in investors’ portfolios. While these themes have potential for wealth creation over the long term, even at this juncture, for participating in equities at current levels, these themes provide margin of safety and potential for absolute as well as relative performance.”

Prateek Pant, CBO, WhiteOak Capital Asset Management also added, “Over the last 18 months, WhiteOak Capital has launched a range of Equity and Hybrid products to provide investors a choice to participate in long term wealth creation. Both these thematic offerings are an opportunity to be a part of a longer-term structural theme. This represents a fundamental view of an investment or market trend based on a deep analysis of macroeconomic, demographic, technological, or other fundamental factors that are expected to shape the market over an extended period.”

(Past performance may or may not be sustained in future and is not a guarantee of any future returns. Index performance does not signify scheme performance.)

(Past performance may or may not be sustained in future and is not a guarantee of any future returns. Index performance does not signify scheme performance. Broader Market here is represented by Nifty 500 TRI.)

WhiteOak Capital has a large and experienced analyst team tracking a large investable universe. The team is well equipped to create a diversified portfolio within the theme with reasonable exposure to high growth emerging opportunities. The fund management team of the WhiteOak Capital Banking & Financial Services Fund includes Trupti Agrawal (Equity), Ramesh Mantri (Equity), Piyush Baranwal (Fixed Income), Shariq Merchant (Overseas Investments). The fund management team of the WhiteOak Capital Pharma and Healthcare Fund will comprise of Ramesh Mantri (Equity), Dheeresh Pathak (Assistant Fund Manager), Piyush Baranwal (Debt), Shariq Merchant (Overseas Investments).

White Oak has a strong performance-first culture, founded on a stock selection-based approach and robust risk management. Its deep bench of seasoned investment team members believes that outsized returns are earned over time by investing in great businesses at attractive valuations. The team employs a proprietary, cash flow based ‘Opco-Finco’ analytical and valuation framework which provides unique insights in contrast to accounting earnings-based models.

Above views are of the author and not of the website kindly read disclaimer